| Product Code: ETC13261153 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Infectious Diseases Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Infectious Diseases Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Infectious Diseases Market Revenues & Volume, 2021 & 2031F |
3.3 North America Infectious Diseases Market - Industry Life Cycle |
3.4 North America Infectious Diseases Market - Porter's Five Forces |
3.5 North America Infectious Diseases Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Infectious Diseases Market Revenues & Volume Share, By Product and Services, 2021 & 2031F |
3.7 North America Infectious Diseases Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 North America Infectious Diseases Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.9 North America Infectious Diseases Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 North America Infectious Diseases Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Infectious Diseases Market Trends |
6 North America Infectious Diseases Market, 2021 - 2031 |
6.1 North America Infectious Diseases Market, Revenues & Volume, By Product and Services, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Infectious Diseases Market, Revenues & Volume, By Assays, 2021 - 2031 |
6.1.3 North America Infectious Diseases Market, Revenues & Volume, By Kits and Reagents, 2021 - 2031 |
6.1.4 North America Infectious Diseases Market, Revenues & Volume, By Instruments, 2021 - 2031 |
6.1.5 North America Infectious Diseases Market, Revenues & Volume, By Services, 2021 - 2031 |
6.1.6 North America Infectious Diseases Market, Revenues & Volume, By Software, 2021 - 2031 |
6.2 North America Infectious Diseases Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Infectious Diseases Market, Revenues & Volume, By Immunodiagnostics, 2021 - 2031 |
6.2.3 North America Infectious Diseases Market, Revenues & Volume, By Clinical Microbiology, 2021 - 2031 |
6.2.4 North America Infectious Diseases Market, Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021 - 2031 |
6.2.5 North America Infectious Diseases Market, Revenues & Volume, By Isothermal Nucleic Acid Amplification Technology (INAAT), 2021 - 2031 |
6.2.6 North America Infectious Diseases Market, Revenues & Volume, By DNA Sequencing and Next-Generation Sequencing (NGS), 2021 - 2031 |
6.2.7 North America Infectious Diseases Market, Revenues & Volume, By DNA Microarray, 2021 - 2031 |
6.2.8 North America Infectious Diseases Market, Revenues & Volume, By Other Technologies, 2021 - 2031 |
6.3 North America Infectious Diseases Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Infectious Diseases Market, Revenues & Volume, By Hepatitis, 2021 - 2031 |
6.3.3 North America Infectious Diseases Market, Revenues & Volume, By Human Immunodeficiency Virus (HIV), 2021 - 2031 |
6.3.4 North America Infectious Diseases Market, Revenues & Volume, By Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG), 2021 - 2031 |
6.3.5 North America Infectious Diseases Market, Revenues & Volume, By Hospital-Acquired Infections (HAIS), 2021 - 2031 |
6.3.6 North America Infectious Diseases Market, Revenues & Volume, By Human Papillomavirus (HPV), 2021 - 2031 |
6.3.7 North America Infectious Diseases Market, Revenues & Volume, By Tuberculosis (TB), 2021 - 2031 |
6.3.8 North America Infectious Diseases Market, Revenues & Volume, By Influenza, 2021 - 2031 |
6.3.9 North America Infectious Diseases Market, Revenues & Volume, By Other Infectious Diseases, 2021 - 2031 |
6.4 North America Infectious Diseases Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.2 North America Infectious Diseases Market, Revenues & Volume, By Hospital/Clinical Laboratories, 2021 - 2031 |
6.4.3 North America Infectious Diseases Market, Revenues & Volume, By Reference Laboratories, 2021 - 2031 |
6.4.4 North America Infectious Diseases Market, Revenues & Volume, By Physician Offices, 2021 - 2031 |
6.4.5 North America Infectious Diseases Market, Revenues & Volume, By Academic/Research Institutes, 2021 - 2031 |
6.4.6 North America Infectious Diseases Market, Revenues & Volume, By Other End Users, 2021 - 2031 |
7 North America Infectious Diseases Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Infectious Diseases Market, Revenues & Volume, By Product and Services, 2021 - 2031 |
7.2.1 United States (US) Infectious Diseases Market, Revenues & Volume, By Product and Services, 2021 - 2031 |
7.2.2 Canada Infectious Diseases Market, Revenues & Volume, By Product and Services, 2021 - 2031 |
7.2.3 Rest of North America Infectious Diseases Market, Revenues & Volume, By Product and Services, 2021 - 2031 |
7.3 North America Infectious Diseases Market Revenues & Volume Share, By Technology, 2021 & 2031F |
7.3.1 United States (US) Infectious Diseases Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.2 Canada Infectious Diseases Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.3 Rest of North America Infectious Diseases Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4 North America Infectious Diseases Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4.1 United States (US) Infectious Diseases Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4.2 Canada Infectious Diseases Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4.3 Rest of North America Infectious Diseases Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.5 North America Infectious Diseases Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United States (US) Infectious Diseases Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Canada Infectious Diseases Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 Rest of North America Infectious Diseases Market, Revenues & Volume, By End User, 2021 - 2031 |
8 North America Infectious Diseases Market Key Performance Indicators |
9 North America Infectious Diseases Market - Export/Import By Countries Assessment |
10 North America Infectious Diseases Market - Opportunity Assessment |
10.1 North America Infectious Diseases Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Infectious Diseases Market Opportunity Assessment, By Product and Services, 2021 & 2031F |
10.3 North America Infectious Diseases Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.4 North America Infectious Diseases Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
10.5 North America Infectious Diseases Market Opportunity Assessment, By End User, 2021 & 2031F |
11 North America Infectious Diseases Market - Competitive Landscape |
11.1 North America Infectious Diseases Market Revenue Share, By Companies, 2022 |
11.2 North America Infectious Diseases Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here